Literature DB >> 15528952

The role of vascular endothelial growth factor in the kidney in health and disease.

Sonia J Wakelin1, Lorna Marson, Sarah E M Howie, James Garden, Jonathan R Lamb, John L R Forsythe.   

Abstract

Vascular endothelial growth factor (VEGF) is a potent endothelial cell mitogen, angiogenic factor and enhancer of vascular permeability. Expressed in the epithelial cells of the developing glomerulus and tubular epithelium, VEGF plays an important role in the development and maintenance of the early vasculature of the kidney. Here, we review the available literature regarding the expression and function of VEGF both in the developing and healthy adult kidney. Furthermore, we highlight how VEGF expression is altered in the diseased kidney and how this modulated expression may impact on and reflect underlying functional changes occurring during the disease process. As discussed, many controversial issues remain, particularly concerning the role of VEGF in the diseased kidney. That VEGF has been proposed as a potential future therapeutic target for the management of some renal diseases requires first that the precise role of VEGF in the normal kidney and various renal pathologies be further and more clearly defined. Copyright 2004 S. Karger AG, Basel.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15528952     DOI: 10.1159/000080686

Source DB:  PubMed          Journal:  Nephron Physiol        ISSN: 1660-2137


  6 in total

1.  Upregulation of sFlt-1 by trophoblasts induces the barrier dysfunction of glomerular endothelial cells.

Authors:  Jun Zhao; Haiyi Liu; Hui Du; Fuyuan Qiao; Yvqi Li; Xinwei Shi; Xun Gong; Yuanyuan Wu; Qiong Zhou; Jingjing Xu
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2011-12-16

Review 2.  Vascular endothelial growth factor from embryonic status to cardiovascular pathology.

Authors:  Mohsen Azimi-Nezhad
Journal:  Rep Biochem Mol Biol       Date:  2014-04

Review 3.  Therapeutic angiogenesis by vascular endothelial growth factor supplementation for treatment of renal disease.

Authors:  Omar C Logue; Jeremy W D McGowan; Eric M George; Gene L Bidwell
Journal:  Curr Opin Nephrol Hypertens       Date:  2016-09       Impact factor: 2.894

4.  Weight-gain induced changes in renal perfusion assessed by contrast-enhanced ultrasound precede increases in urinary protein excretion suggestive of glomerular and tubular injury and normalize after weight-loss in dogs.

Authors:  Daisy J X Liu; Emmelie Stock; Bart J G Broeckx; Sylvie Daminet; Evelyne Meyer; Joris R Delanghe; Siska Croubels; Mathias Devreese; Patrick Nguyen; Evelien Bogaerts; Myriam Hesta; Katrien Vanderperren
Journal:  PLoS One       Date:  2020-04-21       Impact factor: 3.240

Review 5.  The Role of Endocan in Selected Kidney Diseases.

Authors:  Magdalena Nalewajska; Klaudia Gurazda; Małgorzata Marchelek-Myśliwiec; Andrzej Pawlik; Violetta Dziedziejko
Journal:  Int J Mol Sci       Date:  2020-08-25       Impact factor: 5.923

Review 6.  Prognostic and Diagnostic Value of Endocan in Kidney Diseases.

Authors:  Elisabeth Samouilidou; Virginia Athanasiadou; Eirini Grapsa
Journal:  Int J Nephrol       Date:  2022-03-14
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.